NCT03636971View on ClinicalTrials.gov

Gait Analysis Following Knee Viscosupplementation

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 1, 2013

Primary Completion Date

December 30, 2015

Study Completion Date

January 1, 2017

Conditions
GaitKnee OsteoarthritisInjection
Interventions
DRUG

hyaluronic acid with mannitol

single shot injection (Ostenil Plus®, TRB Chemedica SA, CH, 1800kD)

DRUG

hyaluronic acid with sorbitol

single shot injection (Synolis®, Gebro-Pharma AG, CH, 2000 kD)

DRUG

Placebos

single shot injection of saline, same volume

Trial Locations (1)

1011

CHUV - Hopital Orthopedique, Lausanne

All Listed Sponsors
lead

Brigitte Jolles, MD

OTHER

NCT03636971 - Gait Analysis Following Knee Viscosupplementation | Biotech Hunter | Biotech Hunter